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Constraint-based models have become popular methods for systems biology as
they enable the integration of complex, disparate datasets in a biologically cohesive
framework that also supports the description of biological processes in terms of basic
physicochemical constraints and relationships. The scope, scale, and application of
genome scale models have grown from single cell bacteria to multi-cellular interaction
modeling; host-pathogen modeling represents one of these examples at the current
horizon of constraint-based methods. There are now a small number of examples of
host-pathogen constraint-based models in the literature, however there has not yet
been a definitive description of the methodology required for the functional integration
of genome scale models in order to generate simulation capable host-pathogen models.
Herein we outline a systematic procedure to produce functional host-pathogen models,
highlighting steps which require debugging and iterative revisions in order to successfully
build a functional model. The construction of such models will enable the exploration of
host-pathogen interactions by leveraging the growing wealth of omic data in order to
better understand mechanism of infection and identify novel therapeutic strategies.
Keywords: constraint-based model, host-pathogen, optimization methods, mathematical models,
omics-technologies, tuberculosis, salmonella typhimurium, flux balance analysis
Why Constraint-based Modeling for Host-pathogen Interactions?
Rudolph Virchow, a nineteenth century co-founder of pathology is credited with describing
pathology as “physiology with obstacles” and specifying a “diseased state” as a quantitative
deviation from normal function as a result of internal and external (i.e., environmental) influences
(Virchow, 1958). Infections of a host by a pathogen can lead to acute and chronic pathological
conditions. The process of infection by a pathogen can be viewed as a pathological process resulting
from environmental stresses. These causal influences by the pathogen, onto the host, define the
Notations/Abbreviations: h, a host model; p, a pathogen model; hp, a host-pathogen model; BM,h, host biomass pseudo-
reaction; BM,p, pathogen biomass pseudo-reaction; S, the stoichiometric matrix for a metabolic network; v, flux vector in a
metabolic network; x, metabolite vector in a metabolic network; m, the number of unique, compartment specific metabolites
in a stoichiometric matrix, i.e., |x|; n, the number of unique, compartment specific reaction fluxes in a metabolic network, i.e.,
|v|; R, rank of the stoichiometric matrix; Nr, size of the right null space; Nl, size of the right null space; α, biomass optimum
of host model; β, biomass optimum of pathogen model; ǫ, simulation constant for setting lower bound minimum of biomass
production.
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capabilities of the host and its pathogen can be expressed as
constraints on themetabolic capabilities of the host and pathogen
(Figure 1).
The continued development of high-throughput technologies
are enabling profiling of multi-cellular and multi-organism
environments (Gawronski et al., 2009; Han et al., 2010;
Pacchiarotta et al., 2012; McAdam et al., 2014). Such advances
enable the detailed measurement of molecular changes occurring
in host-pathogen interactions (Kim and Weiss, 2008; Stavrinides
et al., 2008; Beste et al., 2013; Le Chevalier et al., 2014; Schoen
et al., 2014; Chang et al., 2015; Henningham et al., 2015; Yao
and Rock, 2015). Generation of these large datasets, in the
context of the complexity of pathogenesis, highlight the need
for systems based approaches for integration into a cohesive
biologically interpretable framework (Durmus et al., 2015).
Constraint-based modeling is an ideal approach for a systematic,
integrated analysis of these data. The approach is based
on well-defined stoichiometric biochemical transformations
(including mass balance, reaction capacity, and directionality)
and gene-protein-reaction (GPR) relationships allow mapping
and integration of multiple, disparate data types. These methods
can incorporate heterogeneous data-types that represent all
hierarchies in the reductionist causal chain of an organism,
thus enabling prediction of emergent properties (Figure 1).
Additionally, constraint-based models circumvent the problem
of over fitting data, which often plagues strictly statistical based
methods. There exist a number of freely available tutorials
and implementation tools and packages enabling the use of
reconstructions for modeling, analysis, and simulation in the
literature (Schellenberger et al., 2011; Liao et al., 2012; Ebrahim
et al., 2013; Sadhukhan and Raghunathan, 2014; Palsson, 2015).
Where in the Tree Do Host-pathogen
Models Lie?
Constraint-based modeling in metabolism has its roots in
microbial organisms, but has progressively grown in the past
decades to describe complex multi-cellular organisms and
various processes (Reed and Palsson, 2003; Mo et al., 2007;
Feist et al., 2009; Karlsson et al., 2011; Osterlund et al.,
2012). There has been a continual, systematic growth and
progression of constraint-based models which initially began
as the formulation of a core biochemical network as a linear
FIGURE 1 | A conceptual representation of integrating constraint-based modeling and omic data. The heterogeneity of omic data (biological constraints) and
their integration is represented in parallel with the phenotypic solution space of the high dimensional host-pathogen model derived from physicochemical constraints.
The degree of constraints represented will depend on the measurement capability and also define a reference set of behaviors that are feasible. (A) enumerates the
heterogeneity of constraints for both host and pathogen and the resultant mathematically feasible and the potential biologically relevant solution space. In (B)
pathogenesis and infection are shown from the perspective of 3 dimensions (i) omics constraints (also determined by experimental constraints) (ii) Annotation detail
(based on existing legacy data) and (iii) the measurement dimensionality (also defining dimensionality of data). (C) shows that understanding host-pathogen interaction
would be possible at multiple scales by integrating heterogeneous data/measurements and constraint-based modeling algorithms. The opportunity afforded by the
legacies of high throughput omics experimentation and systems-level mathematical models would help understand the emergent host-pathogen interaction.
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optimization problem (Papoutsakis, 1984; Fell and Small,
1986; Varma et al., 1993). Further incorporation of additional
layers of biological information through GPRs, thermodynamic
constraints, and various high throughput data have increased
the scope of the models beyond small species metabolism, to
multi-cellular, multi-compartmental organisms (Duarte et al.,
2007; Mo et al., 2007; Herrgård et al., 2008; Lewis et al., 2010;
Ahn et al., 2011; Bordbar et al., 2011; Chang et al., 2011;
Saha et al., 2011; Mintz-Oron et al., 2012; Seaver et al., 2012;
Wang et al., 2012; Pornputtapong et al., 2015). This evolution
in the field has been accompanied by a growth in associated
methodologies (Lewis et al., 2012) and new discoveries (Ellis
et al., 2009; Ahn et al., 2011; Frezza et al., 2011; Thomas et al.,
2014; Väremo et al., 2015). The importance of metabolism
in understanding the process of infections and host pathogen
relationships is increasingly being recognized (Han et al., 2010;
Kafsack and Llinás, 2010; Pacchiarotta et al., 2012; Beste et al.,
2013; Mcconville, 2014; Schoen et al., 2014; Yao and Rock,
2015). The cellular environment and repertoire of available
metabolites is critical in characterizing and understanding how
a pathogen interacts with and infects the host and constraint-
based approaches can provide value insight into mechanisms of
resistance and potentially new drug treatment targets (Chavali
et al., 2008; Huthmacher et al., 2010; Bazzani et al., 2012; Kim
et al., 2013; Shoaie and Nielsen, 2014; Tymoshenko et al., 2015).
In the “evolutionary tree” of constraint-based models, host-
pathogen models lie between multi-cellular models, pathogen
modeling, and new constraints/data integration approaches.
There are now numerous exciting frontiers in the growth of these
models, including the scope, incorporation of physicochemical
constraints, multi-tissue, and multi-organism models (Cakir
et al., 2006; Kümmel et al., 2006a,b; Beg et al., 2007; Duarte
et al., 2007; Mo et al., 2007; Herrgård et al., 2008; Lewis et al.,
2010; Ahn et al., 2011; Bordbar et al., 2011; Chang et al.,
2011; Saha et al., 2011; Metris et al., 2012; Mintz-Oron et al.,
2012; Seaver et al., 2012; Wang et al., 2012; Pornputtapong
et al., 2015). Some of the challenges regarding model integration
will be shared with related areas of multi-cellular constraint-
based modeling, such as modeling microbial communities
(Stolyar et al., 2007; Karlsson et al., 2011; Shoaie and Nielsen,
2014) and the development of new methods characterizing
the interaction between cellular interactions between different
species (Harcombe et al., 2014). Notable differences between
host pathogen modeling and microbial community modeling
include the specification of cellular objectives and constraints
as well as differences in spatial compartmentalization (microbial
community modeling will generally involve interaction through
a shared extracellular space, whereas host pathogen models
may interact through additional compartments; see below). We
confine the scope of this work to focus on host-pathogen
constraint-based modeling that entails the explicit integration of
two genome-scale (or cell scale) constraint-based models. The
purpose of this article is to describe a systematic methodology
leading to successful integration of constraint-based host-
pathogen models. Although there have been a relatively small
number of actual host-pathogen (hp) models reconstructed to
date, the existing studies have produced interesting results and
have taken steps toward elucidating the pathway forward for
future investigations (Raghunathan et al., 2009, 2010; Bordbar
et al., 2010; Sadhukhan and Raghunathan, 2014).
The extracellular environment has an influential effect on
the phenotype state and behavior of cells, thus pathogens
have different biochemical phenotypes when inside the host
versus outside the host and that the host cells will be
affected in some manner by the pathogen and vice-versa.
Many current experimental techniques enable characterization
of these different states (Deatherage Kaiser et al., 2013). The
generation of such data results in the technical challenge of
simultaneous interpretation and analysis of genomic, proteomic,
and/or metabolomics data of two independent, yet interacting
organisms. The ability to derive meaningful interpretations
of such data requires a computational setting which enables
mapping and integrating data in a coherent format that further
allows the data to be analyzed simultaneously, beyond simply
looking at correlations or fitting presumed associations to an
expected model. The constraint-based modeling framework
affords a means to do so.
While there are a seemingly innumerable number of ways that
pathogens have evolved to infect and reside their chosen host
tissues and organs, in general terms there are few places these
organisms can localize: intracellular, extracellular—interstitial,
extracellular—intravascular, extracellular—transcellular, and
“semi-open” spaces (e.g., the respiratory or alimentary tracts,
etc.). In the constraint-based framework, there are three types of
compartment based interactions between the host and pathogen
(defined by the interaction boundary as defined by the pathogen’s
cell wall): extracellular, intracellular:cytosolic, intracellular:intra-
organelle (Figure 2). Within the intracellular environment, there
are multiple compartments that a pathogen may localize and
life cycles of pathogens in some organisms reside in different
compartments, depending on the stage of infection. These details
are organism specific and are addressed on a case-by-case basis.
Reconstructing a Host-pathogen
Constraint-based Model
Formulation of a Description of a Biochemical
Network as a Constraint-based Optimization
Problem
The formulation of metabolic network descriptions in terms of
constraint-based modeling and relation optimization methods
is rooted in applying the principle of mass conservation and
thermodynamic constraints to these networks and has previously
been described in detail (Fell and Small, 1986; Varma et al., 1993;
Orth et al., 2010; Palsson, 2015). Integration of host-pathogen
models requires two curated stoichiometric representations of
metabolic networks, for which the minimum requirements are
a stoichiometric matrix and a flux vector with upper and lower
bounds,
Sh · vh = 0 (1a)
vlbh ≤ vh ≤ v
ub
h (1b)
for the host and,
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FIGURE 2 | Cartoon based schematic representation of different types of interactions between a host and pathogen model, with special attention to
system boundaries. The system boundary is clearly delineated with a solid black line, whereas organism boundaries are dashed lines (the organelle boundary is
represented with a thinner black line. Note that with this formulation, individual models will be required to have exchange reactions for every metabolite that has a
trans-membrane transporter.
Sp · vp = 0 (2a)
vlbp ≤ vp ≤ v
ub
p (2b)
for the pathogen, with Sh∈ R
mh x nh, Sp∈ Rmp x np, vh∈ R
nh, and
vp∈ Rnp (see Notations/Abbreviations).
For host-pathogen modeling, Equations (1) and (2) are not
applied under the strict steady state assumption, but rather along
the lines of a quasi-homeostatic state for which we enforce mass
conservation over a time scale of interest.With this consideration
in mind, the calculation of interest is rarely a specific flux point,
but rather a group of points reflecting a particular flux state (or a
region within the right null space) corresponding to a particular
phenotype that can be differentiated from other qualitatively
different flux states. Identification of such regions often may not
require the specification of a metabolic objective function, in
which case non-objective based methods, such as sampling, may
be appropriate (Savinell and Palsson, 1992; Barrett et al., 2006;
Schellenberger and Palsson, 2009; Bordel et al., 2010).
Pre-existing curated, functional models are a necessary but
not sufficient requirement for building an hp model. Even if
two models are well posed, integration of the two may result in
discrepancies as a result of multiple factors including,
• Error ranges in experimentally derived values (such as biomass
components).
• Incorporation of data from different experimental conditions
that may not be consistent with one another from a mass
balance or thermodynamic perspective.
• Limitations in biological scope of each respective model.
• Lack of knowledge about the true or underlying biological
objectives.
Additional, important considerations to be made when
transitioning from the analysis of an isolated pathogen
to a host-pathogen model include, simulating different
conditions with different data sets, simulating the same
species under different states versus different species under
similar conditions, and specification of the conditions in
which gene lethality knockout/knockdown studies or drug
sensitivity screens are performed and their applicability to host-
pathogen infectious states. These issues highlight the need for a
systematic methodology for integrating host-pathogen models.
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Constraint-based host-pathogen modeling can be viewed as
a generalizable, systematic, multi-tiered process with iterative
sub-steps (Figure 3). Each step includes multiple sub-steps that
require simulations or calculations to be performed, often in
an iterative fashion. A systematic approach for building and
testing the models during the integration process will help make
the debugging process more transparent and the more directed
identification of potential problems.
Step 1. Pre-integration Model Check
This initial step serves as a “sanity check” to avoid problems
during the subsequent integration components of the study.
Although current standards for building curated network
reconstructions generally require critical quality control/quality
assurance steps to avoid spurious behavior from ill-posedmodels,
prior to integration, there are a number of tests that must be
completed for each model to confirm the models have been
constructed and formulated appropriately.
1.i Check mass balances (“No free lunch”). Well curated
models should be free of errors that may lead to violation
of mass conservations constraints. However prior to
integration, each model should be tested to confirm this,
i.e., all uptake exchange reactions should be closed and flux
variability analysis (FVA) (Mahadevan and Schilling, 2003)
should be performed on the entire model, in order to confirm
that there is no net production of any metabolite, when
no substrates are available for uptake. In the toy model
FIGURE 3 | A systematic procedure for successful, functional
integration of a constraint-based host-pathogen model. Details are
described in the main text. The asterisks identify steps that require iterative
revisions if the models fail the corresponding test (see *Iteration/revision
checkpoints in the main text).
depicted in Figure 4, it is clear that if the substrates for the
host and pathogen are not available (Fe, Ae, and De), then
none of the secreted compounds (Be, Xe, Ee, Qe) can be
produced.
1.ii Identify boundary points. The simplest approach for
identification of the boundary points for a model is through
FVA. Although this step can technically be included in
the Functionality Test Suite, FVA is such a useful tool
for debugging and initial assessment of models, that it is
judicious to include this as a mandatory step in the model
integration protocol. Under general uptake conditions (that
are still biologically and thermodynamically feasible), FVA
is performed with subsequent calculation of the flux spans.
This assessment will enable the determination of the ranges
of all reactions and the potential identification of “closed”
reactions, any unbounded reactions, etc.
1.iii Functionality test suite. Prior to integration there
should be a pre-defined set of simulation condition(s) and
reaction optimizations in order to test and confirm desired
functionality of the model (Duarte et al., 2007); this set
of reactions comprise the Functionality Test Suite (FTS).
The FTS can contain any number of desired tests and
simulations to ensure appropriate physiologic behavior of
the model, examples include biomass production under
different growth conditions, specific gene knockout lethality
experiments, inability to growth under specified conditions,
or any other appropriate test that would evaluate the
physiological/biological characterization of the model or the
underlying mathematical definition.
Step 2. Model Integration
Although stoichiometric matrix integration of two models is
trivial from a technical standpoint, the functional integration of a
simulation-capable host and pathogen network reconstruction is
a non-trivial process. The panels in Figure 4 provide a concrete
illustration of the integration of two toy models.
2.i S matrix merge. The stoichiometric matrices are
joined through a compartment specific, row wise-merge
(Figure 4). Generally compartment specific reactions (i.e.,
the compartment in which nutrients are directly exchanged
between the host and pathogen) will not be shared between
the host and pathogen model, however it is important
to confirm this when constructing the new stoichiometric
matrix.
mhp < mh +mp (3)
nhp ≈ nh + np (4)
Note that Equation 3 is defined by an inequality, whereas
Equation (4) is an approximation. The degree of integration
and subsequent complexity of the interactions between the
models is dependent on the number of metabolites that
overlap between the two organisms. If the organisms do not
share any metabolites (mhp = mh + mp), then integration
of the two models will not result in any novel predictions.
On the other hand, the number of reactions in the combined
network may be equal to, less than, or greater than the sum of
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the two individual models. In toy model integration depicted
in Figure 4, mp = 9, mh = 11, and mhp = 18, satisfying the
Equation (3) inequality. For the toy model, Equation (4) is
an equality, since the number of reactions in the combined
model is equal to the sum of the individual models.
2.ii New constraints. Integration of two models includes
the introduction of additional constraints that will make
the simulation environment context specific and more
representative of the actual biological environment.
• Nutrient availability and demand. These constraints are
the most simple to implement and should provide strong
coupling between the host and pathogen. In addition to
biomass (growth and non-growth associated constraints),
additional condition dependent constraints can be
incorporated, for example demands on micronutrients,
sequestration of metabolites, etc. (Rodriguez et al., 2002;
Pan et al., 2010; Weiss and Schaible, 2015). For example
in the toy model (Figure 4), further curation may be
FIGURE 4 | Continued
Frontiers in Microbiology | www.frontiersin.org 6 October 2015 | Volume 6 | Article 1032
Jamshidi and Raghunathan Systematic methodology for constructing host-pathogen models
FIGURE 4 | Continued
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FIGURE 4 | Integration of toy a host cell model with an intracellular pathogen model. (A) depicts a cartoon schematic of a pathogen model, host model, and
integrated host-pathogen model with the corresponding stoichiometric matrices for each of the models (B corresponds to Ai, C corresponds to Aii, and D depicts the
stoichiometric matrix for the hp network in Aiii). Note that when the pathogen “infects” the host the transporters for metabolites B and Q enable usurpation of host
resources and will consequently limit the biomass construction capabilities of the host (potentially the pathogen as well, depending on the size of the demand). In the
provided example, metabolites F and X are not within the intracellular environment of the host, thus R10, R15, and R16 will not be able to carry a flux. In spite of this
however, since there is a transporter for metabolite B, the pathogen biomass can still be produced even though R10 will not be able to carry a flux. It is also possible
that metabolite F and/or X actually are available in the host, but that the particular metabolites were outside the scope of the reconstruction at that time. In this case,
the host model can be updated to include the relevant reactions that would make the metabolites available within the intracellular environment. The multiple points
within the protocol that would allow for evaluation of the appropriateness of including additional reactions during the iterative revisions, particularly Steps 3.iii, 3.iv, and
4.i. Intracellular organelles are not described in this toy example, however if the pathogen infects the host and resides within a particular organelle within the host cell,
the procedure would be the same. Note that the exchange reactions are not explicitly illustrated within the figures, but the columns are present in the stoichiometric
matrices.
needed in order to identify the appropriate bounds for the
intracellular pathogen uptake conditions as well as any
potential new demands on available host nutrients (not
depicted in this example).
• Coupling constraints. The host and pathogen networks
will interact by virtue of the compartment specific shared
metabolites. However, physiologically, the infection of
a host by the pathogen frequently results in additional
interdependencies between the two species, such as
competition for a shared resource. Coupling constraints
are the mathematical relationships formalizing the
explicitly link between the host and pathogen models
together as a constraint. This relationship may take the
form as an interaction between two molecules, concordant
activity between two enzymes, or some other biological
process. For example,
vhi + /− v
p
j = αk (5)
in which αk is a physiologic constant or data dependent
variable (e.g., protein production rates, mRNA expression,
etc.). Non-unity coefficients can be added to the reactions,
if there is known to be a fixed, stoichiometric balance
between the two (or more) reactions. Depending on the
type of relationship represented, this relationship can
be expressed as a continuous flux based problem, or a
discontinuous/discrete problem; the latter would require
formulation as a Mixed Integer Linear Programming
(MILP) problem (Burgard et al., 2001; Phalakornkule et al.,
2001; Pharkya et al., 2004; Kumar and Maranas, 2009).
In the case of hp models, MILP constraints may be used
to express conditionally active reaction constraints. For
example in the toy model depicted in Figure 4, if pathogen
growth (i.e., biomass production, Figure 4Aiii, R12) were
to only occur if the host cell would take up a particular
metabolite (e.g., metabolite D, Figure 4Aiii, R7).
• State changes. To date methodologies for representing
changes in infectious states during an infectious cycle or
a pathogens life cycle have been represented as discrete,
independent simulations. Depending on the type of data
that is available, context specificmodels can be constructed
for each different state or alternatively, conditional, state
dependent constraints MILP constraints can be defined.
2.iii New objectives. Flux balance analysis is an optimization
problem and while there are formulations of the constraint-
based modeling problem that do not require the definition
of a metabolic objective to be optimized (Lewis et al., 2012),
the incorporation of an objective function to be maximized
or minimized is often of great utility, since it enables more
specific predictions to be made by reducing the size of the
steady state solution space (right null space). The definition
and identification of objective functions is an area of great
importance in these models (particularly mammalian cell
models) that is a very rich area for exploration and in need
of further development in the current literature (Khannapho
et al., 2008; Schuetz et al., 2012; Shoval et al., 2012; Szekely
et al., 2013). The flexibility in designing cellular objectives
to tailor hp specific responses is critical for achieving success
with this approach. The biomass objective function has been
discussed in great detail and is generally considered in terms
of two general components: a growth associated component
(accounting for biomass constituent components) and a
non-growth associated component (Feist and Palsson, 2010).
The biomass reaction can be treated as a constraint on
the system or as a prediction to be made by the model
as a means to validate a network reconstruction (Price
et al., 2004). Since the growth of the solution space can
increase dramatically when two models are merged, defining
lower bound constraints on growth associated and non-
growth associated biomass functions for the host or pathogen
is a practical necessity in order to calculate meaningful
results. Organism specific objectives may be developed
from the new constraints that are defined or identified
experimentally.
The specification of appropriate objective functions
requires detailed understanding of pathogen physiology
and host pathogen interactions. These can be separated
into two general categories, single objective and multi-
objective problems (Figure 5). Examples of potential
objective functions include but are not restricted to, the
(pathogen) biomass pseudo-reaction, iron acquisition
(Ratledge and Dover, 2000; Nairz et al., 2015), lactate
dehydrogenase levels as a indicator level of cytotoxicity
(Korzeniewski and Callewaert, 1983; Decker and Lohmann-
Matthes, 1988), enterotoxin production, pathogen specific
metabolite production (Glickman et al., 2000; Takayama
et al., 2005), reactive oxygen species minimization
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FIGURE 5 | Categories and classifications of objective functions in host-pathogen models. The host-pathogen interaction pyramid is shown that integrates
host, pathogen and environment to result in the diseased state phenotype. The diseased state can be queried with the correct formulation of objective functions as
discussed for the three components delineated here. The two sides of the triangle represent the host and the pathogen and the connecting side represents the
environment or niche. The sides converge on the vertex of the prism reflecting the lethal disease state. The space outside the host pathogen interaction prism lists
objectives and their classification. Single objectives help define pathogen or host state, while multi-objectives or weighted objective functions allow definition of
complex phenotypes.
(Brynildsen et al., 2013), and other critical minerals and
metabolites.
Multi-objective functions are more complex, but may
reflect a more accurate representation of the biology
(Gianchandani et al., 2008; Schuetz et al., 2012; Zakrzewski
et al., 2012). The practical challenge is knowledge of the
adequate data to specify these objectives.
• Weighted objectives. New objective functions can be
constructed from the linear combination of reactions
representing cellular demands and requirements. By
combining different reactions together to generate
“compound” or weighted objectives, more complex
behavior can be captured. The obvious weakness of this
approach is that the stoichiometric coefficients are fixed
for the different components, thus this approach is only
applicable in situations in which fluxes (or metabolite
production/consumption) occur in fixed ratios with one
another (as in biomass).
• Bi-level optimizations across host-pathogen boundaries.
Bi-level optimization algorithms designed for
bioengineering and evolutionary objectives (Burgard
et al., 2003; Zomorrodi and Maranas, 2012) can be
extended and applied to understand the dynamics across
host and pathogen during an interaction. Depending
on the experimental conditions, this may include
optimization of pathogen biomass within the host. For
example there may be competing objective functions, as
in the case of maximization of pathogen biomass and
host biomass concurrently or in diametric opposition, i.e.,
maximization of pathogen biomass with minimization of
host substrate availability (either through minimization of
pathogen transport uptake or host transport uptake).
• Multi-level optimization. Although, computationally
intensive, multi-objective optimization (Zakrzewski et al.,
2012; Zomorrodi et al., 2014) can enable a more accurate
representation and in turn more accurate mathematical
simulation of the host-pathogen interaction.
• Step wise algorithmic multi-objectives i.e., sequential
optimizations that apply additional constraints at each
iteration. Iterative optimizations are approach for
including multilayered omic or physiological constraints
allow to be added in order to asses hp behavior in varying
environments or host niche’s (D’Huys et al., 2012). Such
approaches also support the integration of heterogeneous
data types. A limitation of this approach is that the
optimization is order dependent, and thus may be a
more valuable tool for assessing the effects of different
constraints as opposed to a more physiological objective.
2.iv Dimensionality assessment. Dimensionality assessment of
the network includes determining the size of the network,
including the number of metabolites and reactions, as well as
the size of the “functional” space of the network, such as the
right and left null spaces. These components can be directly
calculated from m, n, and the rank of the new stoichiometric
matrix Shp. These quantities can be used to calculate the
size of the right and left null spaces (Nr = n–R and Nl
= m–R). These simple calculations allow assessment of the
dimensionality of the new model (in terms of number of
components and reactions, as well as the steady state solution
space), which will assist in debugging and interpretation of
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TABLE 1 | Descriptive summary of the toy models.
Pathogen Host Host-pathogen
Number of metabolites 9 11 18
Number of reactions 11 13 20
Right null space dimension 2 2 3
Left null space dimension 0 0 1
Rank 9 11 17
Mean betweenness centrality 0.11 2.64 4.33
The sizes of the stoichiometric matrices and the respective right and left null spaces.
The steady state flux states reside in the right null space (calculated from applying mass
conservation constraints). The left null space size describes the number of “conserved”
metabolic moieties. In the case of the toy model, the left null space compound is the
metabolite that cannot be imported into the pathogen, because the host model does not
import or metabolize it.
calculated results and simulations (notably Steps 3 and 4).
Table 1 summarizes these results for the toymodels described
in Figure 4. Knowledge of the right null space in particular is
useful when debugging potential problems and interpreting
simulation results. Integration of the two models results in an
increase in the steady state solution space (i.e., at least 1 new
independent metabolic pathway) as a result of the integration
from the host and pathogen. The left null space contains
the conserved chemical moieties within a network (Famili
and Palsson, 2003; Sauro and Ingalls, 2004). The size and
contents of the left null space can be used to understand how
metabolites may pool together based on network structure
and often provides functional insights (Famili and Palsson,
2003; Thomas et al., 2014).
Additional graph theoretic measures can be calculated
(Girvan and Newman, 2002; Estrada and Rodríguez-
Velázquez, 2005; Fatumo et al., 2011), although their utility in
assessment of functional characteristics and trouble-shooting
in the context of hp model construction is currently limited.
Step 3. Integrated Host-pathogen Testing
On the surface, integration of two models is a trivial step given
the general simplicity of the basic formulation of constraint-
based models. The initial technical challenge is to identify the
overlapping set of metabolites and corresponding abbreviation
mappings between the host and pathogen metabolites.
Although there are laudable efforts to use standardized
nomenclature (Radrich et al., 2010; Dräger and Palsson, 2014),
a persistent challenge in the field is the use of different
abbreviations and nomenclature, which has often required
dedicated efforts to reconcile multiple versions of network
reconstructions (Herrgård et al., 2008; Thiele and Palsson,
2010). Fortunately, however, for host pathogen models, every
metabolite within the two models does not need to be compared,
but rather just the boundary metabolites, which are generally
a fraction of the total number of metabolites in a model.
This is relatively straightforward through the comparison of
abbreviations, if the reconstruction has been appropriately
annotated [e.g., molecular formula, SMILES (Weininger, 1988),
ChEBI (Degtyarenko et al., 2008), etc.]. Once the shared
metabolite complement is identified, the stoichiometric matrices
can be merged (Figure 4). However, “blind” integration without
proper quality control/quality assurance and test conditions in
place, the results will be difficult and quickly overwhelming to
interpret.
The first three sub-steps for Step 3 are similar to Step 1.
Depending on the type and complexity of new constraints
that are applied to the integrated host-pathogen model, there
are situations that may introduce behavior that violates mass
conservation, thus it is necessary to confirm that no “free
metabolites” are produced. For situations in which the pathogen
is an intracellular organism, the test needs to be applied to the
host-pathogen model, as well as the isolated pathogen, within
the host.
3.i Check mass balances. See Step 2. Model Integration, 2.i and
Figure 3, 2.i.
3.ii Identify boundary points. Identification of the right null
space boundary points through FVA of the host-pathogen
draft model will permit a detailed, yet global view of
the capabilities of the combined host-pathogen and enable
comparisons to the individual organisms (Step 1.ii). This
comparison may identify reactions or constraints that may
require revisions to be made. For example, upper bounds
constraints may need to be increased if the combined model
enables the pathogen to exceed the upper limit of some
reactions in comparison to the isolated organism. In the
case of the toy model illustrated in Figure 4 (integrated host
pathogen model), if host’s intracellular environment is much
richer than the “open” environment for the pathogen and in
the infected state, R4 >> R12 (Figure 4Aiii), then the upper
bound of R12 may need be increased in order to permit a
larger potential rate of biomass accumulation.
3.iii The functionality test suite. The functionality test suite
of the combined host-pathogen model will also enable a
basis for comparison with 1.iii and assist subsequent analyses
(Step 4). Note that the FTS for the individual host and
pathogen models may not be identical to the hp set of test
reactions, since the metabolic network capabilities of the host
and pathogen will not be identical in the infected versus
uninfected states.
3.iv Interdependence test This test requires identifying
objective functions that are expected to influence or be
influenced by the coupling between the host and pathogen.
The biomass function is a very good candidate for such
tests, as it is connected to many different pathways within
each respective organism, and subsequently more likely to be
directly connected to the host (or pathogen). The biomass
pseudo-reaction, however, is not the only possible objective
to test and other cellular/metabolic functions may be of
utility, such as ATP production, oxidative phosphorylation,
or constraints on secretion/uptake of particular metabolites
(Schuetz et al., 2007, 2012; Khannapho et al., 2008; García
Saánchez and Torres Sáez, 2014).
The interdependence test involves two steps,
a. Calculate the optimal host biomass production in the
host-pathogen model, then fix the lower bound of the
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host biomass reaction to a specified value (1-ε1) and then
optimize for the biomass of the pathogen:
For α1 = max(v
BM,h
hp ),
set : lower bound(vBM,hhp ) ≥ (1− ε1)α1
max (v
BM,p
hp ) = β2
b. Calculate the optimal pathogen biomass production in
the host-pathogen model, then fix the lower bound of the
pathogen biomass reaction to a specified value (1-ε2) and
then optimize for the biomass of the host:
For β1 = max(v
BM,p
hp ),
set : lower bound(vBM,hhp ) ≥ (1− ε2)β1
max (vBM,hhp ) = α2
Comparison of α1 to α2 as well as β1 to β2 provides an
indication of the degree of coupling between the two models.
If α1 ≈ α2 and β1 ≈ β2, then there is no significant coupling
between the two models. Conversely, if these values are
significantly different from one another then there is evidence
of interaction between the models on a metabolic level. It is
more common to have uni-directional coupling between the
models, often in favor of the pathogen, i.e., β1 ≈ β2 and α1
> α2 due to usurpation of host resources by the pathogen.
The ε coefficients are empiric, simulation based parameter
whose value will vary depending on the specific organism,
the biomass composition, and the media growth conditions.
The “ideal” ε will be large enough to force the consumption
of metabolites and resources required to produce biomass,
but small enough not to introduce a significant bias in the
flux state. When the coefficient ε is equal to 0, then the
interdependence test is equivalent to a stepwise optimization
comparison. Generally the coefficient ε is small, typically
0.01–0.1, when the biomass function is used. A phase portrait
analysis (Edwards et al., 2002) may be useful in assessing
and determining an appropriate ε value. Since ε is a specified
value, the degree of coupling between the host and pathogen
can be titrated to a certain degree. Note that since the growth
rates of the host and pathogenmay be very different from one
another, then ε1 and ε2 may be different from one another.
Since the corners of the right null space generally become
increasingly acute as the size of the model increases, when
the biomass is fixed at the optimum level there is a dramatic
decrease in the available alternative solutions. However when
this constraint is relaxed even by a small amount, the number
of alternative solution points dramatically expands; thus
in order to assess robust coupling between the host and
pathogen, generally a non-zero ε should be chosen.
For example in the toy model depicted in Figure 4,
the pathogen biomass function is dependent on substrates
provided by the host. If the uptake of metabolite A
(Figure 4Aiii, R6) is unbounded (or not known to have
any constraint), then the intra-cellular reproduction of the
pathogen is not significantly constrained and independent
of the host. However, if the host’s uptake of metabolite A
is limited, then the pathogen’s growth rate will be limited.
A common source of error and potential difficulty during
the integration of a host and pathogen model is for the
pathogen biomass production rate lower bound to be set
above the availability of the particular metabolite (i.e., either
the host uptake constraints or the host to pathogen transport
reactions), which results in a non-functional model. In these
cases, the data used for defining the constraints must be
re-evaluated and either the constraints would need to be
revised or there additional reactions would need to be added
to provide alternative routes for availability of the requisite
metabolite(s).
Step 4. Simulation
The type of simulation of interest is principally dependent on (1)
the type of data available, (2) the biological organism of interest,
and (3) the data available to validate or test the simulations.
Due to the broad scope and scale of the realm of possible
simulations, it is not practical to specify a list of calculations that
can be applied for every condition. The purpose of this step is to
assist in bridging the construction of the model to a meaningful
use of the model in the subsequent analysis steps. A common
characteristic of the simulation stage however involves evaluation
steps and the question of how to reconcile inconsistent results
between the model simulations and experimental observations.
Suffice it to say that the use of integrated omic data is one of
the most successful aspects of constraint-based modeling and
there are a number of growing methods being developed for
incorporating genomic sequence, transcriptomic, proteomic, and
metabolomic data; interested readers are referred to available
review articles outlining some of these methods (Blazier and
Papin, 2012; Lewis et al., 2012; Wang et al., 2012; Machado and
Herrgård, 2014; Robaina Estévez and Nikoloski, 2014). For the
purpose of organization and simplifying the debugging process,
the simulation tests can be classified into two general areas,
4.i Physiological constraints. Simulations validating (or
invalidating) predictions of the model using available
physiologic data sets.
4.ii Omic constraints. Simulations validating (or invalidating)
predictions of the hp model through omic data sets.
∗Iteration/revision checkpoints
“Failure” of specific steps in the protocol (Figure 3) requires an
iterative adjustment to be made through revision of the original
models, the integration step, or in some cases further literature
curation and updating of model content or constraints.
1.i Check mass balances (individual models). Failure: Return to
Step 1 (or before). If either the host or the pathogen model result
in violation of mass conservation constraints, then the respective
model needs to be critically evaluated and debugged, so that the
offending reaction(s) is/are identified and removed or adjusted
appropriately. The appropriate definition and representation of
system boundaries is a simple, yet critical step. Consequences
of undefined or inappropriately defined system boundaries will
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lead to an ill-formulated model that will likely result in mass
balance errors. The cartoon illustration in Figure 2 highlights
the appropriate definition of system boundaries when before
and after integration of a host with a pathogen reconstruction.
The most direct and common consequence of poorly defined
boundaries is an ill-formulated description of the optimization
problem with subsequent errors in mass balance, resulting in
irrelevant and even non-sensical results.
Dimensionality assessment
Failure: Return to Step 2.i. “Failure” of this step constitutes
violation of Equation (3). When merging two (or more
reconstructions) there must be a mapping between metabolites
that are shared by each of the two models. At minimum
there must be at least 1 metabolite that is shared between
each model, although in practice there are generally at least
30–40 metabolites that are shared. Once compartment specific
identification of shared metabolites has been performed, then
the two sets of models can be merged through merging the
stoichiometric matrices “row-wise.” If mh + mp = mhp, then
there has likely been an error in integration [either through
formulation of the problem (Step 1) or implementation of the
matrix merge (Step 2.i)]. As noted above, in general, nhp ≈
nh + np, with the approximation being dependent on whether
additional constraints or new objective reactions are added in the
integrated network.
Check mass balances (host-pathogen model)
Failure: Return to 2.i. If the integrated host-pathogen model
results in violation of mass conservation, but the individual
models did not, then there was an error in the model integration
(Steps 2.i-2.iii). Evaluation of the boundary exchanges of the
pathogen should be the first area of critical evaluation.
Functionality test suite
Failure: Return to 1.iii. Depending on the type of error and
the type of functional test, this may be “real” or it may reflect
incomplete knowledge (such as an incompletely defined biomass
function). Failures in the FTS should be analyzed to determine
the source of the limited constraint (the FVA calculations 3.ii can
be helpful in tracking this within the network). Once the cause
of the failure is identified, it needs to be determined if this is the
result of erroneous reaction constraints or a real prediction (i.e.,
a reaction that is active in the “uninfected” state but is inactive in
the infected state). Referral to the primary literature is frequently
needed to resolve these issues.
Interdependence test
Failure: Return to Step 1 and 2.ii. The lack of interdependence
may require revision of the model(s) (through additional
curation and scope expansion) and/or re-assessment of the new
constraints and objective functions that were added. For example,
in the toy model depicted in Figure 4Aiii, further evaluation
of the literature may suggest that R15 and/or R16 are active
in the pathogen during infections, which would require further
evaluation as to how metabolites F and/or X, respectively are
made available to the pathogen inside the host cell.
Simulation
Inconsistencies between model predictions and observed
experimental results or invalidating predictions should first be
assessed in terms of the model and how the specific prediction
was made, i.e., identification of the specific pathways leading to
the calculated results. If there is no evidence to suggest a model
related or numerical error, then there will need to be further
perusal of the literature. For example in Figure 4Aiii, if there is
biochemical or physiologic evidence in the literature suggesting
that biochemical transformation carried out by R10 should be
active (and able to carry a flux) in the infected state, then there
needs to be further evaluation of the literature to determine how
metabolite F is taken into the cell, or if there exists an alternative
pathway for production of metabolite F within the pathogen
(or host). This example also highlights the need for multiple
iterative steps that often necessitate re-evaluation of the primary
literature. In this case, the pathogen is still able to grow within
the host, so there were no errors in Steps 3.i, 3.ii, 3.iii, or 3.iv
(assuming that R10 was not contained in the FTS). This example
is also illustrative of the need for the multiple checkpoints in
the protocol (Figure 3) and the necessity of re-evaluating results
and possibly revising the model(s) at each step of the integration
process.
Current State of the Art and Future Outlook
The systematic procedure described above enables construction
of host-pathogen constraint-based models that is applicable
to organisms ranging from obligate parasites to multi-cellular
pathogens, including viruses, bacteria, and fungi. The methods
described above are most directly relevant and applicable to
bacterial and fungal organisms. Viruses and parasitic organisms
each demonstrate characteristics that may require further
considerations, particularly with respect to conditional (e.g.,
transcription) dependent constraints. Some parasites are multi-
cellular organisms that are capable of residing in multiple
tissues within a host, thus the challenge by some of these
organisms will require the integration of multiple, multi-cellular
models. This process will be more involved, but will include the
same systematic process. One should recognize the importance
of “buffering” compartments and should include them, as
they may play an important role in balancing protons, water,
phosphate, etc.
Achievement of the steps outlined in Figure 3 will result
in a functional host-pathogen model that should represent a
more biologically accurate, quantitative, simulatable description
of the interaction between a host and pathogen (Figure 5),
in turn enabling a more objective, quantitative assessment of
the interactions between these cells. Interrogation of these hp
models would allow probing pathogen adaptation and carbon
source utilization in vivo and host manipulation by pathogen.
Such models should then be used to answer questions regarding
causality during the infection process, condition dependent (or
context specific) differences, and ultimately advance diagnosis
and treatment related challenges by providing an environment to
evaluate and generate hypothesis as well as interpret and analyze
data.
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The ability to measure and represent data on a genome-scale
and the development of constraints based modeling strategies
can help explore the complex host-pathogen interaction space
(Figure 5). While the methods have reached a degree of maturity
that enable the application to a wide range of conditions,
there still remain many areas that deserve further exploration,
including more elegant representation of changes in the
environment (e.g., pH changes between different compartments
and the associated charge changes that may occur with
certain species) as well as more fluid descriptions in the
transitions between different growth stages (e.g., rather than
static representations for each stage, developing the analog of
kinetic models, in which the change from one state to another
can be simulated).
The process of host infection is complex and future
developments will build upon studies that have, for example,
investigated immune responsive signaling pathways such as
the Toll-like receptor (Li et al., 2009) as well as the
dynamics of pathogen metabolism (Penkler et al., 2015). With
continual developments in approaches to expand the scope
of reconstructions (Thiele et al., 2009; Lerman et al., 2012)
and the development of new methods and approaches for
generating genome scale network reconstructions (Overbeek
et al., 2005; Henry et al., 2010; Monk et al., 2013), it is
anticipated that there will be a dramatic rise in the development
of hp models. Ultimately the objective of integrative constraint-
based methods is to develop new strategies for treatment of
pathogenic infections through novel target identification and
new combination therapies for treatment (Trawick and Schilling,
2006; Jamshidi and Palsson, 2007; Karlsson et al., 2011; Chavali
et al., 2012).
Constraint-based modeling allows meeting the challenge of
complex omic data integration across time and space at multiple
levels of hierarchy in the reductionist causal chain to shrink
and explore the solution space of host-pathogen interaction.
On a genome-scale, multi-cellular level, constraint-based hp
modeling has great potential for the prediction of resultant
physiologically perturbed cellular states. Implementation across
these hierarchical levels of resolution (individual metabolites
to mulit-cellular inter-species interactions) at several levels of
abstraction will hopefully lead to further elucidation of the
metabolic underpinnings of the acute and chronic process
of infection, emergent mechanisms of pathogenesis, and
therapeutic strategies to counteract such changes.
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